Sessions Were Renumbered as of May 19.
Legend:
CC-W = McCormick Place Convention Center, West Building,
CC-N = McCormick Place Convention Center, North Building
H = Hilton Chicago,
UC = Conference Chicago at University Center
* = applied session ! = JSM meeting theme
Activity Details
231 * !
Mon, 8/1/2016,
2:00 PM -
3:50 PM
CC-W193a
Application of Novel Methods in Clinical Trials: Case Study Approaches — Topic Contributed Papers
Biometrics Section , Biopharmaceutical Section , International Chinese Statistical Association , Committee on Applied Statisticians
Organizer(s): Arkendu S. Chatterjee, Novartis
Chair(s): Soumi Lahiri, GlaxoSmithKline
2:05 PM
Some New Metrics to Test for Biosimilarity
—
Sujit K. Ghosh, North Carolina State University ; Yifang Li, Novartis
2:25 PM
BOIN: A Simple, Ethical Bayesian Optimal Design for Phase I Oncology Trials
—
Ying Yuan, MD Anderson Cancer Center ; Suyu Liu, MD Anderson Cancer Center
2:45 PM
Early-Phase Designs for Targeted and Immunotherapeutic Agents
—
Codruta Chiuzan, Columbia University
3:05 PM
Using Surrogate Marker Information to Test for a Treatment Effect
—
Layla Parast, RAND Corporation ; Tianxi Cai, Harvard ; Lu Tian, Stanford University
3:25 PM
A Note on Posterior Predictive Assessment to Assess Model Fit
—
Arkendu S. Chatterjee, Novartis ; Dandan Xu, University of Florida ; Michael Daniels, The University of Texas at Austin
3:45 PM
Floor Discussion
